INS and Insulin resistance: Although there were no detected differences in body weights or circulating lipoproteins, MBOAT7 silencing also resulted in insulin resistance, characterized by glucose intolerance, elevated plasma insulin and C-peptide levels, and a reduced ability of insulin to induce insulin receptor β-subunit phosphorylation and downstream Akt phosphorylation in hepatocytes.